Dott. Paraskevi Krashia
Biography
National University of Athens, Greece B.Sc. 1999-2004 Biology
University College London, UK M.Sc. 2004-2005 Neuroscience
University College London, UK Ph.D. 2005-2009 Pharmacology
Curriculum
POSITIONS
2003-2004: Undergraduate Research Student (B.Sc.)
Department of Biology; National and Kapodistrian University of Athens; Athens, Greece; Tutor: Dr SL. Koussoulakos.
2004-2005: Postgraduate Research Student (M.Sc.)
Department of Anatomy and Developmental Biology; University College London (UCL); London, UK; Tutor: Prof. LG. Sivilotti.
2005-2009: Doctoral Research Scientist (Ph.D.)
Department of Neuroscience, Physiology, Pharmacology; University College London (UCL); London, UK; Tutors: Prof. LG. Sivilotti and Prof. D. Colquhoun.
2010-2011: Postdoctoral Researcher
Department of Neuroscience, Physiology, Pharmacology; University College London (UCL); London, UK; PIs: Prof. Stuart G. Cull-Candy and Prof. Mark Farrant
2011-2012: Postdoctoral Research Fellow
Laboratory of Molecular Biology, Neurobiology Division; Medical Research Council; Cambridge, UK; PI: Dr. Ingo Greger
2012-2015: Postdoctoral Researcher
Laboratory of Experimental Neurology, Santa Lucia Foundation IRCCS; Rome, Italy; PI: Prof. Nicola Biaggio Mercuri
2015-2019: Postdoctoral Researcher
Laboratory of Molecular Neurosciences, Santa Lucia Foundation, IRCCS; Rome, Italy; PI: Prof. Marcello D'Amelio
2019-2020: Postdoctoral Research Fellow
Unit of Molecular Neurosciences, University Campus Bio-Medico; Rome, Italy; PI: Prof. Marcello D'Amelio
2020-2026: Fixed-term University Researcher (RTD-A) – Assistant Professor
Faculty of Sciences and Technologies, University Campus Bio-Medico; Rome, Italy
2026-present: Tenure-Track Researcher (RTT)
Faculty of Sciences and Technologies, University Campus Bio-Medico; Rome, Italy
TEACHING ACTIVITIES
2008-2009: Teaching Assistant
Department of Neuroscience, Physiology, Pharmacology; University College London (UCL); UK
Subjects: Neurotoxicology, Neuropharmacology, Molecular Pharmacology
Sept.2009 & 2010: Practical Tutor in Electrophysiology; International Course 'Microelectrode Techniques for Cell Physiology' organized by the UK Physiological Society and Marine Biology Association; Plymouth, UK
2019-present: Assistant Professor
Faculty of Sciences and Technologies and Faculty of Medicine and Surgery, University Campus Bio-Medico; Rome, Italy
Subjects: Human Physiology, Biophysics, Neurophysiology Applied to Nutrition
PUBLICATIONS
• Cauzzi E, Ficchì S, De Paolis ML, Saba L, Montanari M, Loffredo G, La Barbera L, Krashia P, et al. Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked perineuronal-net breakdown and hippocampal disinhibition. Neurobiol Dis. 2026;227:107527.
• La Barbera L, Krashia P, Loffredo G, Cauzzi E, De Paolis ML, Montanari M, et al. Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease. Mol Neurodegener. 2025;20(1):105.
• Ficchì S, Cauzzi E, La Barbera L, De Paolis ML, Loffredo G, Spoleti E, et al Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease. Transl Psychiatry. 2025;15(1):371.
• La Barbera L, Krashia P, Nobili A. How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease. Neural Regen Res. 2025;20(5):1405-1406.
• De Paolis ML, Loffredo G, Krashia P, La Barbera L, Nobili A, et al. Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer's Disease-like deficits in Tg2576 mice. Alzheimers Res Ther. 2025;17(1):94.
• De Paolis ML, Paoletti I, Zaccone C, Capone F, D'Amelio M, Krashia P. Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease. Transl Neurodegener. 2024;13(1):33.
• Spoleti E, La Barbera L, Cauzzi E, De Paolis ML, Saba L, et al Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease. Mol Psychiatry. 2024;29(5):1265-1280.
• La Barbera L, Nobili A, Cauzzi E, Paoletti I, Federici M, Saba L, et al. Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice. Mol Neurodegener. 2022;17(1):76.
• Spoleti E, Krashia P, La Barbera L, Nobili A, Lupascu CA, Giacalone E, et al. Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model. Exp Neurol. 2022;350:113969.
• La Barbera L, Vedele F, Nobili A, Krashia P, Spoleti E, Latagliata EC, et al. Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease. Prog Neurobiol. 2021;202:102031.
• La Barbera L, Vedele F, Nobili A, D'Amelio M, Krashia P. Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. Mol Neurobiol. 2019;56(10):6716-6724.
• Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nat Commun. 2019;10(1):3945.
• Krashia P, Nobili A, D'Amelio M. Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. Front Mol Neurosci. 2019;12:123.
• Nobili A, Krashia P, Cordella A, La Barbera L, Dell'Acqua MC, Caruso A, Pignataro A, Marino R, Sciarra F, et al. Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders. Mol Neurobiol. 2018;55(10):7921–7940.